We propose that targeting the metabolic defects in this pathway might provide an opportunity for the development of kidney cancer gene-specific therapies that are more durable and more effective ...

Metastatic papillary renal cancer has poor outcomes, and new treatments are needed. There is a strong rationale for investigating the combination of mesenchymal epithelial transition receptor (MET) ...

Renal cell carcinoma usually presents as a solid mass ... intrinsic unilocular cystic growth (papillary cystic adenocarcinoma), intrinsic multilocular cystic growth, tumor necrosis resulting ...

From the recently collected papillary calculi ... Their medical histories and lifestyle habits were reviewed, and their renal calculi and urine samples were obtained. The papillae of these ...

The combination of savolitinib and durvalumab demonstrated durable activity in a phase 2 trial of patients with papillary RCC.

Individuals with a family history of kidney cancer or certain genetic conditions, such as von Hippel-Lindau Disease or Hereditary papillary renal cell carcinoma may be at increased risk and should ...

Approximately 1 in 10 patients with Ta low-grade NMIBC recurred after 5 years warrant continued surveillance. Nearly 10% of patients initially diagnosed with Ta low-grade nonmuscle-invasive ...